Literature DB >> 23486661

Reciprocal Negative Regulation between the Guanine Nucleotide Exchange Factor C3G and β-Catenin.

Kunal Dayma1, Anesh Ramadhas, Kotagiri Sasikumar, Vegesna Radha.   

Abstract

The guanine nucleotide exchange factor C3G (RAPGEF1) regulates proliferation, migration, and differentiation of cells and is essential for mammalian embryonic development. The molecular effectors of C3G dependent functions are poorly understood. Here we report that C3G functions as a negative regulator of β-catenin, a major player in pathways known to be deregulated in human cancers. In mammalian cells, C3G is present in a complex with cellular β-catenin. The proline rich Crk binding region of C3G and residues 90-525 of β-catenin are sufficient for the interaction. Knockdown of cellular C3G stimulated, and its overexpression repressed, β-catenin/TCF transcription activity. C3G acts by destabilizing β-catenin protein and inhibiting its nuclear accumulation. Nuclear extracts of C3G overexpressing cells showed reduced binding to TCF consensus oligos. C3G exerts its effects independent of its function as an exchange factor. It also inhibits stability and activity of an N-terminal deletion construct of β-catenin that is not subject to GSK3β dependent phosphorylation, suggesting that C3G exerts its effect independent of GSK3β. β-catenin repression by C3G was not significantly altered in the presence of proteasome inhibitors, MG132 or lactacystin, suggesting that alternate mechanisms are engaged by C3G to cause β-catenin turnover. C3G expression represses β-catenin target gene expression, and stable clones of MCF-7 breast cancer cells expressing C3G showed reduced migration. Activation of cellular β-catenin or expression of constitutively active β-catenin resulted in reduced C3G expression, indicating that C3G gene expression is negatively regulated by β-catenin. Our results identify a novel property of C3G in functioning as a negative regulator of β-catenin signaling by promoting its degradation. In addition, we show that β-catenin inhibits C3G expression, forming a feedback loop.

Entities:  

Keywords:  C3G; GSK3β; guanine nucleotide exchange factor; signaling; β-catenin

Year:  2012        PMID: 23486661      PMCID: PMC3591095          DOI: 10.1177/1947601912471189

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  57 in total

1.  Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis.

Authors:  Timothy F Day; Xizhi Guo; Lisa Garrett-Beal; Yingzi Yang
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

2.  Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway.

Authors:  Donna D Zhang; Shih-Ching Lo; Zheng Sun; Geetha M Habib; Michael W Lieberman; Mark Hannink
Journal:  J Biol Chem       Date:  2005-06-27       Impact factor: 5.157

3.  Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention.

Authors:  Eva Krieghoff; Jürgen Behrens; Bernhard Mayr
Journal:  J Cell Sci       Date:  2006-04-01       Impact factor: 5.285

4.  Inactivation of Crk SH3 domain-binding guanine nucleotide-releasing factor (C3G) in cervical squamous cell carcinoma.

Authors:  K Okino; H Nagai; H Nakayama; D Doi; K Yoneyama; H Konishi; T Takeshita
Journal:  Int J Gynecol Cancer       Date:  2006 Mar-Apr       Impact factor: 3.437

5.  Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells.

Authors:  Susanne Dihlmann; Matthias Kloor; Christine Fallsehr; Magnus von Knebel Doeberitz
Journal:  Carcinogenesis       Date:  2005-05-11       Impact factor: 4.944

6.  Characterization of p87C3G, a novel, truncated C3G isoform that is overexpressed in chronic myeloid leukemia and interacts with Bcr-Abl.

Authors:  Javier Gutiérrez-Berzal; Esther Castellano; Susana Martín-Encabo; Noelia Gutiérrez-Cianca; Jesús M Hernández; Eugenio Santos; Carmen Guerrero
Journal:  Exp Cell Res       Date:  2006-01-27       Impact factor: 3.905

7.  The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling.

Authors:  Chi Hoon Park; Eun Ryeong Hahm; Seyeon Park; Hyun-Kyung Kim; Chul Hak Yang
Journal:  FEBS Lett       Date:  2005-04-21       Impact factor: 4.124

8.  The guanine nucleotide exchange factor, C3G regulates differentiation and survival of human neuroblastoma cells.

Authors:  Vegesna Radha; Ajumeera Rajanna; Rajesh Kumar Gupta; Kunal Dayma; Thiagarajan Raman
Journal:  J Neurochem       Date:  2008-10-24       Impact factor: 5.372

9.  Direct binding of p130(Cas) to the guanine nucleotide exchange factor C3G.

Authors:  K H Kirsch; M M Georgescu; H Hanafusa
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

Review 10.  Regulation of Wnt signaling by protein-protein interaction and post-translational modifications.

Authors:  Akira Kikuchi; Shosei Kishida; Hideki Yamamoto
Journal:  Exp Mol Med       Date:  2006-02-28       Impact factor: 8.718

View more
  5 in total

1.  Development and characterization of a novel monoclonal antibody that recognizes an epitope in the central protein interaction domain of RapGEF1 (C3G).

Authors:  Zareena Begum; Ch Varalakshmi; Divya Sriram; Vegesna Radha
Journal:  Mol Biol Rep       Date:  2018-08-24       Impact factor: 2.316

2.  C3G shows regulated nucleocytoplasmic exchange and represses histone modifications associated with euchromatin.

Authors:  Dhruv Kumar Shakyawar; Kunal Dayma; Anesh Ramadhas; Chavvakula Varalakshmi; Vegesna Radha
Journal:  Mol Biol Cell       Date:  2017-02-01       Impact factor: 4.138

3.  C3G dynamically associates with nuclear speckles and regulates mRNA splicing.

Authors:  Dhruv Kumar Shakyawar; Bhattiprolu Muralikrishna; Vegesna Radha
Journal:  Mol Biol Cell       Date:  2018-05-01       Impact factor: 4.138

4.  Expression of a novel brain specific isoform of C3G is regulated during development.

Authors:  Divya Sriram; Ramulu Chintala; B V V Parthasaradhi; Sanjeev Chavan Nayak; Indumathi Mariappan; Vegesna Radha
Journal:  Sci Rep       Date:  2020-11-02       Impact factor: 4.379

5.  Molecular etiology of an indolent lymphoproliferative disorder determined by whole-genome sequencing.

Authors:  Jeremy D K Parker; Yaoqing Shen; Erin Pleasance; Yvonne Li; Jacqueline E Schein; Yongjun Zhao; Richard Moore; Joanna Wegrzyn-Woltosz; Kerry J Savage; Andrew P Weng; Randy D Gascoyne; Steven Jones; Marco Marra; Janessa Laskin; Aly Karsan
Journal:  Cold Spring Harb Mol Case Stud       Date:  2016-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.